2l60: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: '''Unreleased structure''' The entry 2l60 is ON HOLD Authors: N., N. Description: A novel design concept: New Y-receptor agonists with increased membrane recruitment, Y2 affinity and s... |
No edit summary |
||
| (13 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==A novel design concept: New Y-receptor agonists with increased membrane recruitment, Y2 affinity and selectivity== | |||
<StructureSection load='2l60' size='340' side='right'caption='[[2l60]]' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[2l60]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2L60 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2L60 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | |||
'' | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2l60 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l60 OCA], [https://pdbe.org/2l60 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2l60 RCSB], [https://www.ebi.ac.uk/pdbsum/2l60 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2l60 ProSAT]</span></td></tr> | ||
</table> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | |||
[[Category: Large Structures]] | |||
[[Category: Jensen KJ]] | |||
[[Category: Jurt S]] | |||
[[Category: Pedersen NL]] | |||
[[Category: Zerbe O]] | |||
Latest revision as of 06:09, 27 November 2024
A novel design concept: New Y-receptor agonists with increased membrane recruitment, Y2 affinity and selectivity
| ||||||||||||
